The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study
Open accessAbstract
Microglial activation is implicated in the pathogenesis of ALS and can be detected in animal models of the disease that demonstrate increased survival when treated with anti-inflammatory drugs. PK11195 is a ligand for the "peripheral benzodiazepine binding site" expressed by activated microglia. Ten ALS patients and 14 healthy controls underwent [(11)C](R)-PK11195 PET of the brain. Volumes of interest were defined to obtain [(11)C](R)-PK11195 regional binding potential values for motor and "extra-motor" regions. Significantly increased binding was found in motor cortex (P = 0.003), pons (P = 0.004), dorsolateral prefrontal cortex (P = 0.010) and thalamus (P = 0.005) in the ALS patients, with significant correlation between binding in the motor cortex and the burden of upper motor neuron signs clinically (r = 0.73, P = 0.009). These findings indicate that cerebral microglial activation can be detected in vivo during the evolution of ALS, and support the previous observations that cerebral pathology is widespread. They also argue for the development of therapeutic strategies aimed at inflammatory pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“presumably due to increased CNS microglia or their activation, as suggested by positron emission tomography (PET) imaging using radiotracers specific for activated microglia [423,424].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [424]
In the citing paper
“Postmortem studies308–310 and in vivo PET studies311–313 revealed widespread cerebral microglial activation in patients with ALS,308–312 and even in pre-symptomatic ALS-related mutation carriers.309,313”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [311]
In the citing paper
“Microglial activation in middle frontal and superior or middle temporal gyrus regions was also highly found in vivo PET imaging studies in humans”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [311]
Citations
Cites
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,400
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
Simplified Reference Tissue Model for PET Receptor Studies
Lammertsma, A. A., & Hume, S. P. (1996) · NeuroImage · doi:10.1006/nimg.1996.0066 · Cited by 2,025
Rowland, L. P., & Shneider, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442207 · Cited by 1,913
From charcot to lou gehrig: deciphering selective motor neuron death in als
Cleveland, D. W., & Rothstein, J. D. (2001) · Nature reviews. Neuroscience · doi:10.1038/35097565 · Cited by 1,389
Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model
Gunn, R. N., Lammertsma, A. A., Hume, S. P., & Cunningham, V. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0303 · Cited by 1,085
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,069
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054
Self-citationThe overlap of amyotrophic lateral sclerosis and frontotemporal dementia
Lomen, C. E., Anderson, T. T., & Miller, B. L. (2002) · Neurology · doi:10.1212/wnl.59.7.1077 · Cited by 699
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–737 of 737
Shape Alterations of Subcortical Nuclei Correlate With Amyotrophic Lateral Sclerosis Progression
Yuan, Y., Fu, Y. H. H., Wang, X., Hu, F., Zhao, Q., He, C., Tang, L., Li, Y., Bu, Y., Song, X., et al. (2025) · Brain and Behavior · doi:10.1002/brb3.70495
Über die Auswirkungen systemischer bakterieller Begleitinfektionen bei Amyotropher Lateralsklerose
Zech, W. (2007) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-711
Cox, L. M., Calcagno, N., Gauthier, C. D., Madore, C., Butovsky, O., & Weiner, H. L. (2022) · Figshare · doi:10.6084/m9.figshare.19343149
Cox, L. M., Calcagno, N., Gauthier, C. D., Madore, C., Butovsky, O., & Weiner, H. L. (2022) · Figshare · doi:10.6084/m9.figshare.19343143
Cox, L. M., Calcagno, N., Gauthier, C. D., Madore, C., Butovsky, O., & Weiner, H. L. (2022) · Figshare · doi:10.6084/m9.figshare.19343155
Chang, C.-W., Chiu, C.-H., Lin, M.-H., Wu, H.-M., Yu, T.-H., Wang, P.-Y., Kuo, Y.-Y., Huang, Y.-Y., Shiue, C.-Y., Huang, W.-S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14227913
Cox, L. M., Calcagno, N., Gauthier, C. D., Madore, C., Butovsky, O., & Weiner, H. L. (2022) · Figshare · doi:10.6084/m9.figshare.19343152
Additional file 1 of Quantitative patterns of motor cortex proteinopathy across ALS genotypes
Nolan, M., Scott, C., Gamarallage, M. P., Lunn, D., Carpenter, K., McDonough, E., Meyer, D. E., Kaanumalle, S., Santamaria-Pang, A., Turner, M. R., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12607271
Self-citationCox, L. M., Calcagno, N., Gauthier, C. D., Madore, C., Butovsky, O., & Weiner, H. L. (2022) · Figshare · doi:10.6084/m9.figshare.19343140
Cox, L. M., Calcagno, N., Gauthier, C. D., Madore, C., Butovsky, O., & Weiner, H. L. (2022) · Figshare · doi:10.6084/m9.figshare.19343146
Cox, L. M., Calcagno, N., Gauthier, C. D., Madore, C., Butovsky, O., & Weiner, H. L. (2022) · Figshare · doi:10.6084/m9.figshare.19343137
Wang, F., Zhang, K., Zhu, L., Li, W., Wu, Y., Gao, X., Ma, X., Yin, X., Wu, J., Ye, X., et al. (2026) · Advanced Science · doi:10.1002/advs.202512149
Sharbafshaaer, M., Pirozzi, M. A., Caiazzo, G., Canale, F., Silvestro, M., Russo, A., Tessitore, A., Esposito, F., & Trojsi, F. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1757470
Takahashi, K., Quan, Z., Shigemoto‐Mogami, Y., Zhang, B., Ohwada, T., Abe, I., Awakawa, T., & Sato, K. (2026) · ACS Omega · doi:10.1021/acsomega.5c12080
Aebischer, J. (2011) · theses.fr (ABES) · doi:10.70675/7dc30612zb4b4z49a3z864bz8fa2e995aa0e
Gerber, Y. N. (2011) · theses.fr (ABES) · doi:10.70675/4234ace7z72a4z4873z9ec5zc82a77a8cce9
La neuroimmunité dans la sclérose latérale amyotrophique
Coque, E. (2017) · theses.fr (ABES) · doi:10.70675/30e0135azd2a1z4ee4zaeb7za9ba7cf0f4d3
Implication des macrophages périphériques dans la Sclérose latérale Amyotrophique
Chiot, A. (2018) · theses.fr (ABES) · doi:10.70675/e3d90f5az237az4722zbff2z9c99590e826b
Unravelling the tangle of motor neuron diseases : insights from neuroimaging and neurophysiology
Querin, G. (2019) · theses.fr (ABES) · doi:10.70675/30ad3e2az5051z4364z9ec1z4b8d1f952b7b
Novel FUS and CHCHD10 models to investigate pathogenic mechanisms in Amyotrophic Lateral Sclerosis
Bourefis, A.-R. (2019) · theses.fr (ABES) · doi:10.70675/45ab8515z9859z430fzb472z306dd61206c8
Etude des effets thérapeutiques de la protéine X du virus Borna chez la souris SOD1G93A
Tournezy, J. (2024) · theses.fr (ABES) · doi:10.70675/6679c9cez7694z4a71z84a3za0e24b70e3eb
Étude du rôle du métabolisme musculaire dans la Sclérose Latérale Amyotrophique
Cheguillaume, F. (2024) · theses.fr (ABES) · doi:10.70675/7b287199z7c58z4355z99abzb7f52797d631
Slaghekke, H. M. J., Govaarts, R., Mesarosova, L., Mühlebner, A., Beeldman, E., de Visser, M., van Es, M. A., van den Berg, L. H., van der Kooi, A. J., Pijnenburg, Y. A. L., et al. (2026) · Journal of Neurology · doi:10.1007/s00415-026-13848-4
Pavey, N., Tu, S., Foster, S., Geevasinga, N., Calma, A. D., Tsuji, Y., Kiernan, M. C., Vucic, S., & Menon, P. (2026) · Clinical Neurophysiology · doi:10.1016/j.clinph.2026.2111949
Nanotherapeutics targeting neuroinflammation
Chaulagain, B., Tagoe, B., Gothwal, A., Mahanta, A. K., Muolokwu, C. E., Lamsal, B., & Singh, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33623-2.00013-1
Russell, K. A., Shahrabi, A. A., Akerman, S. C., Byrne, M. D., Rothstein, J. D., Trotti, D., Jensen, B. K., & Haeusler, A. R. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02341-8
Gündüz, A., Şi̇ri̇n, N. G., Boran, H. E., Baslo, S. A., Baslo, M. B., Kuruoğlu, H. R., Orhan, E. K., Öge, A. E., Yildiz, F. G., Tümer, O., et al. (2026) · Clinical Neurophysiology · doi:10.1016/j.clinph.2026.2112331
Viljoen, S. J., Chaves, J. C. S., Peall, I. W., White, A. R., & Oikari, L. E. (2026) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2026.126168
Serum neurofilament and measures of lower motor neuron dysfunction in amyotrophic lateral sclerosis
Calma, A. D., Pavey, N., Tsuji, Y., Ghapar, A. A., Orden, B., Lee, G., Mekhael, L., Ryder, J., Silva, C. S., Menon, P., et al. (2026) · Clinical Neurophysiology · doi:10.1016/j.clinph.2026.2112428
Dissecting cross-talk between microglia and motoneurons in ALS: signaling events and soluble factors
Barbosa, M. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Metadata
- Authors
- Turner, M. R., Cagnin, A., Turkheimer, F. E., Miller, C. C. J., Shaw, C. E., Brooks, D. J., Leigh, P. N., & Banati, R. B.
- Affiliations
- King's College London (GB)
- University of Padua (IT)
- Hammersmith Hospital (GB)
- Corresponding author
- Turner, M.R
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 15
- Issue
- 3
- Pages
- 601-609
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2019706623
- Cited by
- 737
- References
- 90
- Citations by year
- 2026: 15 · 2025: 23 · 2024: 37 · 2023: 31 · 2022: 40 · 2021: 52 · 2020: 52 · 2019: 43 · 2018: 43 · 2017: 44 · 2016: 42 · 2015: 42 · 2014: 47 · 2013: 42 · 2012: 27
- FWCI
- 15.87
- Type
- journal article
- Language
- en
- Open access
- green
- doaj.org
- Licence
- Locations
- Neurobiology of Disease (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Portal (King's College London) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- amyotrophic lateral sclerosis, microglial activation, [11C]PK11195, positron emission tomography, translocator protein (TSPO), motor cortex, passive optical networks, dorsolateral prefrontal cortex, thalamus, upper motor neuron signs, neuroinflammation, neuropathology
- MeSH terms
- Adult, Amyotrophic Lateral Sclerosis, Brain, Female, Humans, Isoquinolines, Male, Middle Aged, Tomography, Emission-Computed, Microglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review